Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 Date Wednesday, June 08, 2022 - 6:00 PM Description
Protection Due to Previous SARS-CoV-2 Infection Date Wednesday, June 08, 2022 - 8:00 AM Description To the Editor: Although it is true that the effectiveness of previous SARS-CoV-2 infection in preventing reinfection varies across the spectrum that encompasses the B.1.1.7 (alpha), B.1.351 (beta), B.1.617.2 (delta), and B.1.1.529 (omicron) variants
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients Date Wednesday, June 08, 2022 - 8:00 AM Description
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Date Saturday, June 04, 2022 - 11:00 PM Description
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer Date Wednesday, June 01, 2022 - 6:00 PM Description
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine Date Wednesday, June 01, 2022 - 6:00 PM Description